The epithelial cell-derived danger signal mediators interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP) have emerged as key players in the intricate network of adaptive Th2 immune responses associated with asthma. This evidence concerns the gene IL33 and asthma.